🔥AGITG MASTERPLAN🔥 Borderline resectable or Locally advanced PDAC n=75 🔍Randomized 3m mFOLFIRINOX or Gem+nab-Paclitaxel alone +/- SBRT (40 Gy/5 fx) Primary endpoint: locoregional recurrence 🚨SBRT had improved: ✅12 m LRR: 20% vs. 50% ✅mOS 22m vs. 14 m #ESMO26 https://t.co/Y1L97YhT3J